Oncology

Filter

New Clues to Early Melanoma Development

June 2025

A new study uncovers how melanomas can arise from minimal genetic changes, shedding light on the early, often elusive steps in skin cancer progression

Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse

Immatics announced enrolment of patients into a phase I trial of its first adoptive cellular therapy (ACT) IMA101.

Colorectal Cancer Risk Reduced by a Mediterranean Diet

RISK of colorectal cancer can be reduced by consuming certain components of the Mediterranean diet, according to data presented at the European…

Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role of Genomic Testing in Treatment of Early Breast Cancer

Geneva, Switzerland, 12 July, 2017 – Genomic Health today announced that the 15th St. Gallen International Breast Cancer Conference Expert Panel endorsed…

Agendia’s MammaPrint® Recommended by ASCO Breast Cancer Guideline in Focused Update Based on Landmark MINDACT Trial Data

ASCO recommends MammaPrint® for clinical high risk, hormone receptor-positive, HER2-negative breast cancer, to inform decisions on withholding chemotherapy

PharmaMar Announces Encouraging Results in Clinical Trials of Lurbinectedin in Endometrial and Breast Cancers

PharmaMar announces encouraging results in clinical trials of Lurbinectedin in endometrial and breast cancers. Find out more

Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting

Oxford, UK and Conshohocken, US, 5 June, 2017 – Immunocore Limited, the world’s leading TCR company developing biological drugs to treat cancer…

F-Star Expands Its Relationship with Merck Through a New Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology

Cambridge, UK, June 04, 2017 – F-star, a biopharmaceutical company developing novel bispecific antibodies, announces today a new partnership with Merck…

Darzalex®▼ (daratumumab) Combination Therapy Improved Clinical Outcomes Regardless of Cytogenetic Risk for Previously-Treated Patients with Multiple Myeloma

Beerse, Belgium, June 4, 2017 – Janssen-Cilag International NV (“Janssen”) today announced new data from updated analyses of the pivotal Phase 3 CASTOR…

Loading posts...

« Previous 1 … 36 37 38 39 40 … 51 Next »